Covered recipient · General Payments record
ZOLTAN GOMBOS
Allopathic & Osteopathic Physicians Pathology Anatomic Pathology & Clinical Pathology
General Payments · PY2019–2024
$4,283.56
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $806.30 | 2 |
| Food and Beverage | $553.78 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| bioMerieux | $1,223.47 | 6 |
| Merck Sharp & Dohme Corporation | $45.80 | 2 |
| EISAI INC. | $43.21 | 2 |
| Genentech USA, Inc. | $25.93 | 1 |
| Cepheid | $21.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| bioMerieux Inc | $32.61 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147099850 | CMS |
| bioMerieux Inc | $2.22 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147100346 | CMS |
| bioMerieux Inc | $8.29 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147100348 | CMS |
| bioMerieux Inc | $489.63 | 10/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1147099524 | CMS |
| bioMerieux Inc | $316.67 | 11/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1147099660 | CMS |
| bioMerieux Inc | $374.05 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147099772 | CMS |
| Cepheid | $21.67 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128534532 | CMS |
| Eisai Inc. | $19.85 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110790436 | CMS |
| Eisai Inc. | $23.36 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110790434 | CMS |
| Genentech USA, Inc. | $25.93 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133137038 | CMS |
| Merck Sharp & Dohme LLC | $16.99 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141935713 | CMS |
| Merck Sharp & Dohme LLC | $28.81 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141731078 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.